Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOVENT BIO

92.250
+0.3000.33%
Volume:9.77M
Turnover:906.65M
Market Cap:158.12B
PE:-1.45K
High:94.300
Open:91.100
Low:90.650
Close:91.950
52wk High:109.100
52wk Low:28.650
Shares:1.71B
HK Float Shares:1.71B
Volume Ratio:0.79
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.064
ROE:8.43%
ROA:2.65%
PB:10.02
PE(LYR):-1,449.67
PS:12.65

Loading ...

Innovent Biologics Announces Promising Clinical Study Results for Picankibart in Psoriasis at EADV Congress 2025

Reuters
·
Sep 16

Fangzhou Says in Partnership With Innovent to Integrate Co's H2h Digital Health Ecosystem With Innovent's Pipeline of Weight-Management Therapies

THOMSON REUTERS
·
Sep 14

BRIEF-Fangzhou Launches “Xingshi” LLM, Says in Innovent, Otsuka Tie-up

Reuters
·
Sep 14

Fangzhou Says in Collaboration With Zhejiang Otsuka Pharmaceutical to Jointly Develop Comprehensive Digital Solutions

THOMSON REUTERS
·
Sep 14

Fangzhou Inc Says Co Has Launched Its Proprietary “Xingshi” Large Language Model

THOMSON REUTERS
·
Sep 14

China Securities Co., Ltd.: Innovative Drug Globalization Drives Pharmaceutical Industry Chain Recovery

Stock News
·
Sep 13

GLMS SEC Maintains "BUY" Rating for INNOVENT BIO (01801) as Profitability Shows Significant Improvement

Stock News
·
Sep 12

Hong Kong Stock Alert | Fangzhou Jianke (06086) Surges Over 7% Intraday on Strategic Partnership with Innovent Bio to Build New "AI+Weight Management" Service Model

Stock News
·
Sep 12

GLMS SEC Maintains "Buy" Rating for INNOVENT BIO (01801) with Strong H1 2025 Performance Growth

Stock News
·
Sep 11

Market Chatter: China Healthcare Sector's Fundraising Expected to Reach Record in 2025, Analysts Say

MT Newswires Live
·
Sep 10

Fangzhou Inc. and Innovent Biologics Forge Strategic Alliance for AI-Driven Weight Management Solutions

Reuters
·
Sep 10

FANGZHOU JIANKE (06086) Forms Strategic Partnership with INNOVENT BIO, Targeting Billion-Dollar Market with "AI + Weight Management" Integration

Stock News
·
Sep 10

GF Securities: Industry's Medium to Long-term Positive Trend Established, BD Deals Are Just the Starting Point of This Round of Innovative Drug Value Revaluation

Stock News
·
Sep 10

Tianfeng Securities: Weight Loss Market Continues to Expand, MNC Pipeline Expectations Gap May Accelerate Domestic Molecular BD Landing

Stock News
·
Sep 10

Hong Kong Stock Concept Tracker | Multiple Innovative Drug Companies Have Key Research Selected for WCLC Oral Presentations, Current Period May Still Present Optimal Timing for Innovative Drug Allocation (with Concept Stocks)

Stock News
·
Sep 10

China Merchants International: Chinese Pharmaceutical Stocks Expected to Continue Rising on Innovation Drug Overseas Expansion and Domestic Policy Optimization, Recommends Buying 3SBIO (01530) and Others

Stock News
·
Sep 08

Innovent Biologics Announces Promising Phase 2 Results of Tigulixostat for Gout Treatment at APLAR Congress

Reuters
·
Sep 08

Innovent Announces Phase 2 Results of Tigulixostat (Ibi128, Xoi) in Gout Patients Were Published at the 27TH Asia-Pacific League of Associations for Rheumatology Congress

THOMSON REUTERS
·
Sep 08

Jefferies Raises INNOVENT BIO Target Price to HK$105, Maintains "Buy" Rating

Stock News
·
Sep 02

ICBC Credit Suisse Fund Manager Zhao Bei's Mid-Year Report Released! INNOVENT BIO (01801) and ZAI LAB (09688) Enter Top Ten Holdings

Stock News
·
Sep 02